Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Viktor Brabec
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Phenomena
Physiology
Living Beings
Sign-in to see full Profile
Network (preview)
40
Kasparkova, Jana
23
Kaspárková, Jana
22
Vrána, Oldrich
21
Farrell, Nicholas
19
Nováková, Olga
16
Natile, Giovanni
15
Malina, Jaroslav
14
Novakova, Olga
13
Sadler, Peter
9
Gibson, Dan
8
Balcarová, Z
8
Najajreh, Yousef
8
Marini, Victoria
7
Hofr, Ctirad
7
Vrana, Oldrich
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Viktor Brabec (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Zerzankova Lenka; Suchankova Tereza; Vrana Oldrich; Farrell Nicholas P; Brabec Viktor; Kasparkova Jana
Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.
Biochemical pharmacology 2010;79(2):112-21.
-
2009: Malina Jaroslav; Vrana Oldrich; Brabec Viktor
Mechanistic studies of the modulation of cleavage activity of topoisomerase I by DNA adducts of mono- and bi-functional PtII complexes.
Nucleic acids research 2009;37(16):5432-42.
-
2009: Heringova Pavla; Kasparkova Jana; Brabec Viktor
DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2009;14(6):959-68.
-
2009: Nováková Olga; Malina Jaroslav; Kaspárková Jana; Halámiková Anna; Bernard Vladan; Intini Francesco; Natile Giovanni; Brabec Viktor
Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+.
Chemistry (Weinheim an der Bergstrasse, Germany) 2009;15(25):6211-21.
-
2009: Nováková Olga; Nazarov Alexey A; Hartinger Christian G; Keppler Bernhard K; Brabec Viktor
DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media.
Biochemical pharmacology 2009;77(3):364-74.
-
2009: Suchánková Tereza; Vojtísková Marie; Reedijk Jan; Brabec Viktor; Kaspárková Jana
DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2009;14(1):75-87.
-
2008: Bugarcic Tijana; Habtemariam Abraha; Stepankova Jana; Heringova Pavla; Kasparkova Jana; Deeth Robert J; Johnstone Russell D L; Prescimone Alessandro; Parkin Andrew; Parsons Simon; Brabec Viktor; Sadler Peter J
The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Inorganic chemistry 2008;47(24):11470-86.
-
2008: Kasparkova Jana; Marini Victoria; Bursova Vendula; Brabec Viktor
Biophysical studies on the stability of DNA intrastrand cross-links of transplatin.
Biophysical journal 2008;95(9):4361-71.
-
2008: Bugarcic Tijana; Nováková Olga; Halámiková Anna; Zerzánková Lenka; Vrána Oldrich; Kaspárková Jana; Habtemariam Abraha; Parsons Simon; Sadler Peter J; Brabec Viktor
Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes.
Journal of medicinal chemistry 2008;51(17):5310-9.
-
2008: Castellano-Castillo Maria; Kostrhunova Hana; Marini Victoria; Kasparkova Jana; Sadler Peter J; Malinge Jean-Marc; Brabec Viktor
Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2008;13(6):993-9.
-
2008: Kostrhunova Hana; Florian Jakub; Novakova Olga; Peacock Anna F A; Sadler Peter J; Brabec Viktor
DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media.
Journal of medicinal chemistry 2008;51(12):3635-43.
-
2008: Malina Jaroslav; Hannon Michael J; Brabec Viktor
DNA binding of dinuclear iron(II) metallosupramolecular cylinders. DNA unwinding and sequence preference.
Nucleic acids research 2008;36(11):3630-8.
-
2008: Halámiková Anna; Heringová Pavla; Kaspárková Jana; Intini Francesco P; Natile Giovanni; Nemirovski Alina; Gibson Dan; Brabec Viktor
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine.
Journal of inorganic biochemistry 2008;102(5-6):1077-89.
-
2008: Hegmans Alexander; Kasparkova Jana; Vrana Oldrich; Kelland Lloyd R; Brabec Viktor; Farrell Nicholas P
Amide-based prodrugs of spermidine-bridged dinuclear platinum. Synthesis, DNA binding, and biological activity.
Journal of medicinal chemistry 2008;51(7):2254-60.
-
2008: de Mier-Vinué Jordi; Gay Marina; Montaña Angel M; Sáez Rosa-Isabel; Moreno Virtudes; Kasparkova Jana; Vrana Oldrich; Heringova Pavla; Brabec Viktor; Boccarelli Angela; Coluccia Mauro; Natile Giovanni
Synthesis, biophysical studies, and antiproliferative activity of platinum(II) complexes having 1,2-bis(aminomethyl)carbobicyclic ligands.
Journal of medicinal chemistry 2008;51(3):424-31.
-
2008: Malina Jaroslav; Hannon Michael J; Brabec Viktor
Interaction of dinuclear ruthenium(II) supramolecular cylinders with DNA: sequence-specific binding, unwinding, and photocleavage.
Chemistry (Weinheim an der Bergstrasse, Germany) 2008;14(33):10408-14.
-
2008: Kasparkova Jana; Vojtiskova Marie; Natile Giovanni; Brabec Viktor
Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Chemistry (Weinheim an der Bergstrasse, Germany) 2008;14(4):1330-41.
-
2007: Mackay Fiona S; Woods Julie A; Heringová Pavla; Kaspárková Jana; Pizarro Ana M; Moggach Stephen A; Parsons Simon; Brabec Viktor; Sadler Peter J
A potent cytotoxic photoactivated platinum complex.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(52):20743-8.
-
2007: Malina Jaroslav; Novakova Olga; Vojtiskova Marie; Natile Giovanni; Brabec Viktor
Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.
Biophysical journal 2007;93(11):3950-62.
-
2007: Halamikova Anna; Vrana Oldrich; Kasparkova Jana; Brabec Viktor
Biochemical studies of the thermal effects on DNA modifications by the antitumor cisplatin and their repair.
Chembiochem : a European journal of chemical biology 2007;8(16):2008-15.
-
2007: Melchart Michael; Habtemariam Abraha; Novakova Olga; Moggach Stephen A; Fabbiani Francesca P A; Parsons Simon; Brabec Viktor; Sadler Peter J
Bifunctional amine-tethered ruthenium(II) arene complexes form monofunctional adducts on DNA.
Inorganic chemistry 2007;46(21):8950-62.
-
2007: Knipp Markus; Karotki Andrei V; Chesnov Serge; Natile Giovanni; Sadler Peter J; Brabec Viktor; Vasák Milan
Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.
Journal of medicinal chemistry 2007;50(17):4075-86.
-
2007: Vrána Oldrich; Masek Vlastimil; Drazan Viktor; Brabec Viktor
Raman spectroscopy of DNA modified by intrastrand cross-links of antitumor cisplatin.
Journal of structural biology 2007;159(1):1-8.
-
2007: Magennis Steven W; Habtemariam Abraha; Novakova Olga; Henry John B; Meier Samuel; Parsons Simon; Oswald Iain D H; Brabec Viktor; Sadler Peter J
Dual triggering of DNA binding and fluorescence via photoactivation of a dinuclear ruthenium(II) arene complex.
Inorganic chemistry 2007;46(12):5059-68.
-
2007: Brabec Viktor; Christofis Petros; Slámová Martina; Kostrhunová Hana; Nováková Olga; Najajreh Yousef; Gibson Dan; Kaspárková Jana
DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Biochemical pharmacology 2007;73(12):1887-900.
-
2007: Gallmeier Eike; Hucl Tomas; Brody Jonathan R; Dezentje David A; Tahir Khola; Kasparkova Jana; Brabec Viktor; Bachman Kurtis E; Kern Scott E
High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cells.
Cancer research 2007;67(5):2169-77.
-
2007: Moriarity Branden; Nováková Olga; Farrell Nicholas; Brabec Viktor; Kaspárková Jana
1,2-GG intrastrand cross-link of antitumor dinuclear bifunctional platinum compound with spermidine linker inhibits DNA polymerization more effectively than the cross-link of conventional cisplatin.
Archives of biochemistry and biophysics 2007;459(2):264-72.
-
2007: Malina Jaroslav; Hannon Michael J; Brabec Viktor
Recognition of DNA three-way junctions by metallosupramolecular cylinders: gel electrophoresis studies.
Chemistry (Weinheim an der Bergstrasse, Germany) 2007;13(14):3871-7.
-
2007: Chválová Katerina; Brabec Viktor; Kaspárková Jana
Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.
Nucleic acids research 2007;35(6):1812-21.
-
2006: Heringova Pavla; Woods Julie; Mackay Fiona S; Kasparkova Jana; Sadler Peter J; Brabec Viktor
Transplatin is cytotoxic when photoactivated: enhanced formation of DNA cross-links.
Journal of medicinal chemistry 2006;49(26):7792-8.
-
2006: Kaspárková Jana; Nováková Olga; Vrána Oldrich; Intini Francesco; Natile Giovanni; Brabec Viktor
Molecular aspects of antitumor effects of a new platinum(IV) drug.
Molecular pharmacology 2006;70(5):1708-19.
-
2006: Chválová Katerina; Kaspárková Jana; Farrell Nicholas; Brabec Viktor
Deoxyribonuclease I footprinting reveals different DNA binding modes of bifunctional platinum complexes.
The FEBS journal 2006;273(15):3467-78.
-
2006: Najajreh Yousef; Ardeli-Tzaraf Yael; Kasparkova Jana; Heringova Pavla; Prilutski Dmitri; Balter Liliana; Jawbry Seba; Khazanov Elena; Perez Jose Manuel; Barenholz Yechezkel; Brabec Viktor; Gibson Dan
Interactions of platinum complexes containing cationic, bicyclic, nonplanar piperidinopiperidine ligands with biological nucleophiles.
Journal of medicinal chemistry 2006;49(15):4674-83.
-
2006: Najajreh Yousef; Khazanov Elena; Jawbry Seba; Ardeli-Tzaraf Yael; Perez Jose Manuel; Kasparkova Jana; Brabec Viktor; Barenholz Yechezkel; Gibson Dan
Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
Journal of medicinal chemistry 2006;49(15):4665-73.
-
2006: Brabec Viktor; Nováková Olga
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2006;9(3):111-22.
-
2006: Ramos-Lima Francisco J; Vrána Oldrich; Quiroga Adoración G; Navarro-Ranninger Carmen; Halámiková Anna; Rybnícková Hana; Hejmalová Lenka; Brabec Viktor
Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.
Journal of medicinal chemistry 2006;49(8):2640-51.
-
2006: Brabec Viktor; Stehlíková Kristýna; Malina Jaroslav; Vojtiísková Marie; Kaspárková Jana
Thermodynamic properties of damaged DNA and its recognition by xeroderma pigmentosum group A protein and replication protein A.
Archives of biochemistry and biophysics 2006;446(1):1-10.
-
2006: Stehlíková Kristýna; Kaspárková Jana; Nováková Olga; Martínez Alberto; Moreno Virtudes; Brabec Viktor
Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complex.
The FEBS journal 2006;273(2):301-14.
-
2006: Pivonková Hana; Brázdová Marie; Kaspárková Jana; Brabec Viktor; Fojta Miroslav
Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain.
Biochemical and biophysical research communications 2006;339(2):477-84.
-
2005: Najajreh Yousef; Kasparkova Jana; Marini Victoria; Gibson Dan; Brabec Viktor
Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2005;10(7):722-31.
-
2005: Malina Jaroslav; Vojtiskova Marie; Brabec Viktor; Diakos Connie I; Hambley Trevor W
DNA adducts of the enantiomers of the Pt(II) complexes of the ahaz ligand (ahaz=3-aminohexahydroazepine) and recognition of these adducts by HMG domain proteins.
Biochemical and biophysical research communications 2005;332(4):1034-41.
-
2005: Brabec Viktor; Kasparkova Jana
Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2005;8(3):131-46.
-
2005: Delalande Olivier; Malina Jaroslav; Brabec Viktor; Kozelka Jirí
Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent.
Biophysical journal 2005;88(6):4159-69.
-
2005: Najajreh Yousef; Prilutski Dmitri; Ardeli-Tzaraf Yael; Perez Jose Manuel; Khazanov Elena; Barenholz Yechezkel; Kasparkova Jana; Brabec Viktor; Gibson Dan
Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand.
Angewandte Chemie (International ed. in English) 2005;44(19):2885-7.
-
2005: Hofr Ctirad; Brabec Viktor
Thermal stability and energetics of 15-mer DNA duplex interstrand crosslinked by trans-diamminedichloroplatinum(II).
Biopolymers 2005;77(4):222-9.
-
2005: Bursova Vendula; Kasparkova Jana; Hofr Ctirad; Brabec Viktor
Effects of monofunctional adducts of platinum(II) complexes on thermodynamic stability and energetics of DNA duplexes.
Biophysical journal 2005;88(2):1207-14.
-
2005: Novakova Olga; Kasparkova Jana; Bursova Vendula; Hofr Ctirad; Vojtiskova Marie; Chen Haimei; Sadler Peter J; Brabec Viktor
Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity.
Chemistry & biology 2005;12(1):121-9.
-
2005: Marini Victoria; Christofis Petros; Novakova Olga; Kasparkova Jana; Farrell Nicholas; Brabec Viktor
Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].
Nucleic acids research 2005;33(18):5819-28.
-
2004: Kasparkova Jana; Vrana Oldrich; Farrell Nicholas; Brabec Viktor
Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
Journal of inorganic biochemistry 2004;98(10):1560-9.
-
2004: Kloster Miriam; Kostrhunova Hana; Zaludova Renata; Malina Jaroslav; Kasparkova Jana; Brabec Viktor; Farrell Nicholas
Trifunctional dinuclear platinum complexes as DNA-protein cross-linking agents.
Biochemistry 2004;43(24):7776-86.
-
2004: Prokop Radim; Kasparkova Jana; Novakova Olga; Marini Victoria; Pizarro Ana María; Navarro-Ranninger Carmen; Brabec Viktor
DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
Biochemical pharmacology 2004;67(6):1097-109.
-
2004: Kasparkova Jana; Fojta Miroslav; Farrell Nicholas; Brabec Viktor
Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
Nucleic acids research 2004;32(18):5546-52.
-
2003: Chen Haimei; Parkinson John A; Nováková Olga; Bella Juraj; Wang Fuyi; Dawson Alice; Gould Robert; Parsons Simon; Brabec Viktor; Sadler Peter J
Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):14623-8.
-
2003: Kasparkova Jana; Novakova Olga; Najajreh Yousef; Gibson Dan; Perez Jose-Manuel; Brabec Viktor
Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
Chemical research in toxicology 2003;16(11):1424-32.
-
2003: Novakova Olga; Kasparkova Jana; Malina Jaroslav; Natile Giovanni; Brabec Viktor
DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
Nucleic acids research 2003;31(22):6450-60.
-
2003: Kasparkova Jana; Novakova Olga; Marini Victoria; Najajreh Yousef; Gibson Dan; Perez Jose-Manuel; Brabec Viktor
Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
The Journal of biological chemistry 2003;278(48):47516-25.
-
2003: Novakova Olga; Chen Haimei; Vrana Oldrich; Rodger Alison; Sadler Peter J; Brabec Viktor
DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Biochemistry 2003;42(39):11544-54.
-
2003: Kaspárková Jana; Mackay Fiona S; Brabec Viktor; Sadler Peter J
Formation of platinated GG cross-links on DNA by photoactivation of a platinum(IV) azide complex.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2003;8(7):741-5.
-
2003: Kasparkova Jana; Marini Victoria; Najajreh Yousef; Gibson Dan; Brabec Viktor
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Biochemistry 2003;42(20):6321-32.
-
2003: Fojta Miroslav; Pivonkova Hana; Brazdova Marie; Kovarova Lucie; Palecek Emil; Pospisilova Sarka; Vojtesek Borivoj; Kasparkova Jana; Brabec Viktor
Recognition of DNA modified by antitumor cisplatin by "latent" and "active" protein p53.
Biochemical pharmacology 2003;65(8):1305-16.
-
2003: Kasparkova Jana; Delalande Olivier; Stros Michal; Elizondo-Riojas Miguel-Angel; Vojtiskova Marie; Kozelka Jiri; Brabec Viktor
Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
Biochemistry 2003;42(5):1234-44.
-
2003: Kasparkova Jana; Novakova Olga; Farrell Nicholas; Brabec Viktor
DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Biochemistry 2003;42(3):792-800.
-
2002: Kasparkova Jana; Zehnulova Jana; Farrell Nicholas; Brabec Viktor
DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair.
The Journal of biological chemistry 2002;277(50):48076-86.
-
2002: Benedetti Michele; Malina Jaroslav; Kasparkova Jana; Brabec Viktor; Natile Giovanni
Chiral discrimination in platinum anticancer drugs.
Environmental health perspectives 2002;110 Suppl 5():779-82.
-
2002: Vrana Oldrich; Brabec Viktor
L-methionine inhibits reaction of DNA with anticancer cis-diamminedichloroplatinum(II).
Biochemistry 2002;41(36):10994-9.
-
2002: Marini Victoria; Kasparkova Jana; Novakova Olga; Monsú Scolaro Luigi; Romeo Raffaello; Brabec Viktor
Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2002;7(7-8):725-34.
-
2002: Brabec Viktor; Kasparkova Jana
Molecular aspects of resistance to antitumor platinum drugs.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2002;5(3-4):147-61.
-
2002: Stehlikova Kristyna; Kostrhunova Hana; Kasparkova Jana; Brabec Viktor
DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent.
Nucleic acids research 2002;30(13):2894-8.
-
2002: Janovská Eva; Nováková Olga; Natile Giovanni; Brabec Viktor
Differential genotoxic effects of antitumor trans-[PtCl(2)(E-iminoether)(2)] and cisplatin in Escherichia coli.
Journal of inorganic biochemistry 2002;90(3-4):155-8.
-
2002: Malina Jaroslav; Kasparkova Jana; Natile Giovanni; Brabec Viktor
Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
Chemistry & biology 2002;9(5):629-38.
-
2002: McGregor Tracey D; Hegmans Alexander; Kaspárková Jana; Neplechová Kamila; Nováková Olga; Penazová Hana; Vrána Oldrich; Brabec Viktor; Farrell Nicholas
A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2002;7(4-5):397-404.
-
2002: Brabec Viktor
DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.
Progress in nucleic acid research and molecular biology 2002;71():1-68.
-
2001: Missura M; Buterin T; Hindges R; Hübscher U; Kaspárková J; Brabec V; Naegeli H
Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair.
The EMBO journal 2001;20(13):3554-64.
-
2001: Zehnulova J; Kasparkova J; Farrell N; Brabec V
Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464.
The Journal of biological chemistry 2001;276(25):22191-9.
-
2001: Hofr C; Farrell N; Brabec V
Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
Nucleic acids research 2001;29(10):2034-40.
-
2001: Kasparkova J; Pospisilova S; Brabec V
Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53.
The Journal of biological chemistry 2001;276(19):16064-9.
-
2001: Malina J; Novakova O; Keppler B K; Alessio E; Brabec V
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2001;6(4):435-45.
-
2001: Hofr C; Brabec V
Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer.
The Journal of biological chemistry 2001;276(13):9655-61.
-
2000: Nováková O; Hofr C; Brabec V
Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl(2)(Me(2)SO(4))(4)Ru] in cell-free media.
Biochemical pharmacology 2000;60(12):1761-71.
-
2000: Kostrhunova H; Brabec V
Conformational analysis of site-specific DNA cross-links of cisplatin-distamycin conjugates.
Biochemistry 2000;39(41):12639-49.
-
2000: Brabec V; Neplechova K; Kasparkova J; Farrell N
Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2000;5(3):364-8.
-
2000: Kasparkova J; Farrell N; Brabec V
Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
The Journal of biological chemistry 2000;275(21):15789-98.
-
2000: Malina J; Hofr C; Maresca L; Natile G; Brabec V
DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.
Biophysical journal 2000;78(4):2008-21.
-
1999: Loskotová H; Brabec V
DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin.
European journal of biochemistry / FEBS 1999;266(2):392-402.
-
1999: McGregor T D; Balcarová Z; Qu Y; Tran M C; Zaludová R; Brabec V; Farrell N
Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes.
Journal of inorganic biochemistry 1999;77(1-2):43-6.
-
1999: Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Biochemistry 1999;38(34):10997-1005.
-
1999: Neplechová K; Kaspárková J; Vrána O; Nováková O; Habtemariam A; Watchman B; Sadler P J; Brabec V
DNA interactions of new antitumor aminophosphine platinum(II) complexes.
Molecular pharmacology 1999;56(1):20-30.
-
1999: Brabec V; Kaspárková J; Vrána O; Nováková O; Cox J W; Qu Y; Farrell N
DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
Biochemistry 1999;38(21):6781-90.
-
1998: Zákovská A; Nováková O; Balcarová Z; Bierbach U; Farrell N; Brabec V
DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
European journal of biochemistry / FEBS 1998;254(3):547-57.
-
1998: Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo M F; Natile G; Brabec V
DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
Molecular pharmacology 1998;53(5):846-55.
-
1997: Zaludová R; Zákovská A; Kaspárkova J; Balcarová Z; Vrána O; Coluccia M; Natile G; Brabec V
DNA modifications by antitumor trans-[PtCl2(E-iminoether)2].
Molecular pharmacology 1997;52(3):354-61.
-
1997: Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
European journal of biochemistry / FEBS 1997;246(2):508-17.
-
1997: Zaludová R; Natile G; Brabec V
The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA.
Anti-cancer drug design 1997;12(4):295-309.
-
1996: Kaspárková J; Mellish K J; Qu Y; Brabec V; Farrell N
Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies.
Biochemistry 1996;35(51):16705-13.
-
1996: Vrána O; Boudný V; Brabec V
Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II).
Nucleic acids research 1996;24(20):3918-25.
-
1996: Zaludová R; Kleinwächter V; Brabec V
The effect of ionic strength on melting of DNA modified by platinum(II) complexes.
Biophysical chemistry 1996;60(3):135-42.
-
1996: Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini F P; Coluccia M; Natile G
DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
Nucleic acids research 1996;24(2):336-41.
-
1995: Kaspárková J; Brabec V
Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
Biochemistry 1995;34(38):12379-87.
-
1995: Nováková O; Kaspárková J; Vrána O; van Vliet P M; Reedijk J; Brabec V
Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes.
Biochemistry 1995;34(38):12369-78.
-
1995: Nováková O; Vrána O; Kiseleva V I; Brabec V
DNA interactions of antitumor platinum(IV) complexes.
European journal of biochemistry / FEBS 1995;228(3):616-24.
-
1994: Brabec V; Boudný V; Balcarová Z
Monofunctional adducts of platinum(II) produce in DNA a sequence-dependent local denaturation.
Biochemistry 1994;33(6):1316-22.
-
1993: Brabec V; Balcarova Z
Restriction-enzyme cleavage of DNA modified by platinum(II) complexes.
European journal of biochemistry / FEBS 1993;216(1):183-7.
-
1992: Balcarová Z; Mrázek J; Kleinwächter V; Brabec V
Cleavage by restriction enzymes of DNA modified with the antitumour drug cis-diamminedichloroplatinum(II).
General physiology and biophysics 1992;11(6):579-88.
-
1992: Vrána O; Kiseleva V I; Poverenny A M; Brabec V
Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis.
European journal of pharmacology 1992;226(1):5-13.
-
1992: Boudný V; Vrána O; Gaucheron F; Kleinwachter V; Leng M; Brabec V
Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes.
Nucleic acids research 1992;20(2):267-72.
-
1991: Brabec V; Vrana O; Kiseleva V I; Poverenny A M
Polyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments.
European journal of biochemistry / FEBS 1991;201(3):723-30.
-
1991: Kogan E M; Dyatlova N G; Sidorova N S; Vilner L M; Vrána O; Brabec V
Biophysical studies of the complexes of polyriboguanylic acid with brominated and chlorinated polyribocytidylic acids.
Biophysical chemistry 1991;40(3):231-9.
-
1991: Brabec V; Vrána O; Platonova G A; Kogan E M; Sidorova N S
Biophysical studies of the modification of poly(rG) . poly(rC) by cisplatin. Relations to the biological activity of the complex.
Chemico-biological interactions 1991;78(1):1-12.
-
1990: Brabec V; Kleinwächter V; Butour J L; Johnson N P
Biophysical studies of the modification of DNA by antitumour platinum coordination complexes.
Biophysical chemistry 1990;35(2-3):129-41.
-
1989: Balcarová Z; Brabec V
Reinterpretation of fluorescence of terbium ion-DNA complexes.
Biophysical chemistry 1989;33(1):55-61.
-
1988: Brabec V; Vucelic D
Adsorption of human beta 2-microglobulin at a water/mercury interface.
Biophysical chemistry 1988;29(3):271-6.
-
1987: Kasparová D; Vrána O; Kleinwächter V; Brabec V
The effect of platinum derivatives on interfacial properties of DNA.
Biophysical chemistry 1987;28(3):191-7.
-
1986: Vrána O; Brabec V; Kleinwächter V
Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity.
Anti-cancer drug design 1986;1(2):95-109.
-
1984: Vrána O; Kleinwächter V; Brabec V
Polarographic activity of the antitumor drug cis-dichlorodiammineplatinum (II). The effect of hydrolysis and trans-isomerization of the drug.
Experientia 1984;40(5):446-51.
-
1983: Vrána O; Kleinwächter V; Brabec V
Determination of platinum in urine by differential pulse polarography.
Talanta 1983;30(4):288-90.
Sign-in to see more